Latest News & Updates

Breaking News

  • 8 hours ago

  • Team Pharma Now

CPHI Frankfurt Pharma Awards 2025 Finalists Announced
Breaking News
Tonix Pharmaceuticals In-Licenses Phase 2/3-Ready Monoclonal Antibody TNX-4800 For Seasonal Prevention Of Lyme Disease

Simantini Singh Deo

Other trending news you may like to read

CPHI Frankfurt Pharma Awards 2025 Finalists Announced

Hundreds of entries received across 14 categories showcasing innovation, sustainability, and leadership in pharma

Team Pharma Now

Pharma Now

Tonix Pharmaceuticals In-Licenses Phase 2/3-Ready Monoclonal Antibody TNX-4800 For Seasonal Prevention Of Lyme Disease

Tonix licenses TNX-4800, a single-dose antibody designed to prevent Lyme disease across the entire U.S. tick season.

Simantini Singh Deo

Pharma Now

Palisade Bio Highlights Positive Data From PALI-2108 Phase 1b Clinical Evaluation

Palisade Bio reports strong Phase 1b data for PALI-2108 in ulcerative colitis, showing rapid response and anti-fibrotic potential.

Simantini Singh Deo

Pharma Now

Invivyd Announces Appointment of Communications Expert Kristie Kuhl As Chief Communications Officer

Invivyd appoints Kristie Kuhl as Chief Communications Officer to lead strategy and patient advocacy for its antiviral pipeline.

Simantini Singh Deo

Pharma Now